HEAL-Tx: Health Advocate for Adolescent Liver Transplant Recipients

This study is testing a program called "Health Advocate" (HEAL-Tx) to see if having a dedicated advocate can help young people (ages 18-25) who have had a liver transplant transition smoothly to adult care. The Health Advocate will help with things like finding food or housing, improving communication with doctors, and coordinating care. We want to see if this program is practical and well-received by patients and their families. To join, you must have received a liver transplant over a year ago, be between 18 and 25 years old, and have a social need (like food insecurity) or a certain risk score. The study plans to enroll 20 participants, but the current recruitment status is unclear.

Study design
This is a pilot study, meaning it's a small-scale test of the Health Advocate intervention. It is open-label, so everyone involved will know they are receiving the intervention. There will be 20 participants.
What's involved
You will participate in the Health Advocate program. Your experience will be measured at the beginning of the study and again after 180 days.
Compensation
Not stated in the trial record.
Follow-up
Your patient experience will be measured at baseline and again after 180 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06386198

HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients

Recruiting
NAAges 18–25InterventionalSupportive care
University of California, San Francisco
~20 participants
Updated 2026-08-11 on ClinicalTrials.gov
What's tested:Health Advocate

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Changes in patient experience
Measured over Baseline and 180 days
Liver Transplant; Complications
2 sites across 2 states
California1
Georgia1
  • Sharad Wadhwani, MD, MPH · PRINCIPAL_INVESTIGATOR · University of California, San Francisco

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Patient has significant cognitive impairment.
Does not meet age criteria
Patient is a ward of the state.
Non-English, non-Spanish speakers.
Non-US residents.
  • Changes in patient experienceBaseline and 180 days

    The investigators will administer a survey of patient experience at study enrollment and at the end of the intervention to assess for changes in patient experience with the transplant team. These questions will focus on experiences receiving transplant care, experiences discussing social needs with the transplant team, and overall subjective assessment of the transplant recipient's overall health.